跳至主要内容
临床试验/EUCTR2015-002060-17-FR
EUCTR2015-002060-17-FR进行中(未招募)1 期

Effect of pharmacological heart rate reduction on visco-elastic properties of the arterial wall - Impact of aging - BRADY-VASC

CHU - Hôpitaux de Rouen0 个研究点目标入组 30 人开始时间: 2015年8月5日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Healthy subject
  • Aged between 25 and 65 years old
  • Resting heart rate mesured three times after a rest period of 15 min = 70 bpm
  • No significant ECG abnormality
  • No significant biological abnormality
  • Childbearing age women must have effective contraception (estrogen-progestin contraceptives, intrauterin device or tubal ligation). Will be considered postmenopausal women with amenorrhea for more than 2 years
  • Able to read and understand information form and to give written informed consent
  • Subjects with medical insurance
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Subjects who don’t understand French language
  • Subjects deprived of liberty by an administrative or judicial decision or protected adult subject (under guardianship)
  • Pregnant women, nursing mother or women without contraception
  • Subjects who participate to an other trial / participated to an other interventional research without drugs during the last month or a trial with drugs during the last 3 months
  • Hypersensitivity to the active substance or to any of the excipients
  • Congenital galactosemia, lactase deficiency (Lapp), malabsorption of glucose and galactose
  • Severe hypotension, mesured three times after a rest period of 15 min (< 90/50 mmHg)
  • Essential or secondary hypertension, mesured three times after a rest period of 15 min (SBP =140 mmHg and/or DBP =90 mmHg)
  • Smoking at the day of inclusion (>5 cigarettes/day)
  • Severe hypercholesterolemia (Total cholesterol >2,5 g/L)
  • Subjects who practice sports intensively (= 1 hour/day)
  • Renal insufficiency (creatinine clearance = 60 ml/min/1,73 m² Cockroft and Gault formula)
  • Known liver failure
  • Known heart failure or suspected heart failure (congestive episode)
  • Atrial fibrillation
  • High-grade conduction block (Sick sinus syndrome, sino-atrial block or grade 2 or 3 atrio-ventricular block)
  • Abnormal corrected QT with Bazett formula (cQT > 450 ms (men) or > 470 ms (women)).
  • All cardiac or no cardiac diseases, active or with sequelae, which, in the opinion of the investigator, is accompanied by a risk of cardiac or vascular abnormality
  • Known retinal disease
  • Subject disagrees with the prohibition of taking grapefruit juice, millepertuis or any medication during the study except oral contraceptive, acetaminophene or decision of the investigator. (annex n°02)
  • Administration of any medication listed in anex n°02 (aspirin, NSAID and inhibitors of cytochrome P450 3A4) during the previous week.

研究者

发起方
CHU - Hôpitaux de Rouen

相似试验